Pharma supply chains

Major Swiss retailers face tampons shortage amid price negotiations

Tampax tampon products on a supermarket shelf

This content was published on May 9, 2026 Feminine hygiene products have been disappearing from Swiss supermarket shelves, as several retailers negotiate prices with American giant Procter & Gamble.

Novartis closes plant in Germany, 220 jobs away

Workplace

Novartis to close site in Germany and cut 220 jobs

This content was published on May 6, 2026 Swiss drugmaker Novartis plans to cut around 220 jobs in Germany as part of the planned closure of a production site in Wehr ⁠by the end of 2028.

Novartis opens seventh plant in the United States

New treatments

Swiss pharma firm Novartis plans seventh US plant

This content was published on Apr 30, 2026 Novartis is expanding its production capacity in the United States, with the announcement of a new site in Morrisville, North Carolina. This plant will bring to seven the number of new sites planned as part of its $23 billion investment plan.

Pharma supply chains

From Covid to Hormuz, what has Switzerland learned about drug shortages?

This content was published on Apr 23, 2026 While immediate drug shortages aren't expected, experts say the Middle East conflict could impact medicine availability in Switzerland.

Full transparency from the FOPH on Covid-19 vaccines

Drug pricing

Swiss court forces Covid vaccine procurement transparency

This content was published on Apr 16, 2026 Court forces Switzerland to release unredacted Covid vaccine contracts from the pandemic.

A supercomputer is being powered on during a photo op.

AI and medicine

Explainer: why Roche’s supercomputer is a big deal

This content was published on Mar 26, 2026 Pharma companies are racing to acquire microchips and achieve the most powerful AI capacity in the industry. But drug development is tricky and AI talents scarce.

Pharma supply chains

Lonza sells off its capsules division to British firm

This content was published on Mar 7, 2026 The Swiss firm is selling its capsules and health ingredients business to Lone Star Funds for CHF2.3 billion ($3 billion).

The banking sector has been particularly affected by redundancies.

Pharma supply chains

Why unemployment in Switzerland is increasing more than elsewhere in Europe

This content was published on Feb 24, 2026 The number of people in Switzerland who are out of work increased for the second year in a row. This contrasts with the situation in the European Union.

Healthcare innovation

Swiss pharma’s global success meets worries at home

This content was published on Feb 13, 2026 Switzerland’s two biggest pharmaceutical companies are doing well. Why is the country so worried?

Novartis: new global biomedical research centre opens in San Diego

Pharma supply chains

Novartis begins construction of new research centre in San Diego, US

This content was published on Feb 9, 2026 Novartis has begun work on a new global biomedical research centre in San Diego, United States. The 43,300 m2 facility will be operational in 2029 and house around 1,000 employees.

Pharma supply chains

Popular Stories

Most Discussed

Pharma supply chains

More

Major Swiss retailers face tampons shortage amid price negotiations

More

Novartis to close site in Germany and cut 220 jobs

More

Swiss pharma firm Novartis plans seventh US plant

More

From Covid to Hormuz, what has Switzerland learned about drug shortages?

More

Swiss court forces Covid vaccine procurement transparency

More

Explainer: why Roche’s supercomputer is a big deal

More

Lonza sells off its capsules division to British firm

More

Why unemployment in Switzerland is increasing more than elsewhere in Europe

More

Swiss pharma’s global success meets worries at home

More

Novartis begins construction of new research centre in San Diego, US

Popular Stories

Most Discussed